PRODUCTION OF PURIFIED RECOMBINANT VIRAL PROTEINS PRODUC

Information

  • Research Project
  • 3635160
  • ApplicationId
    3635160
  • Core Project Number
    N01CP095645
  • Full Project Number
    N01CP095645-000
  • Serial Number
    95645
  • FOA Number
  • Sub Project Id
  • Project Start Date
    2/28/1989 - 35 years ago
  • Project End Date
    1/25/1991 - 33 years ago
  • Program Officer Name
  • Budget Start Date
    2/28/1989 - 35 years ago
  • Budget End Date
    2/1/1990 - 34 years ago
  • Fiscal Year
    1989
  • Support Year
  • Suffix
  • Award Notice Date
    -
Organizations

PRODUCTION OF PURIFIED RECOMBINANT VIRAL PROTEINS PRODUC

The project requires the contractor to supply the following Proteins: (1) 200 mg each of three (3) purified recombinant human viral proteins produced in insect cells from HIV-l envelope gene fragments. (2) 5-10 mg of purified SIV envelope proteins (gp160 and gp41/32) suitable for animal vaccine studies. (3) Prepare and supply monoclonal and polyclonal antibodies to three selected proteins.

IC Name
DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS
  • Activity
    N01
  • Administering IC
    CP
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    393
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
  • Study Section Name
  • Organization Name
    REPLIGEN CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    WALTHAM
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02453
  • Organization District
    UNITED STATES